Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
a study on Anemia Sickle Cell Anemia
Summary
- Eligibility
- for people ages 6 years and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT02187003
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated